Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor

Most gastrointestinal stromal tumors (GIST) are driven by activating mutations in Proto-oncogene c-KIT (KIT) or PDGFRA receptor tyrosine kinases (RTK). The emergence of effective therapies targeting these mutations has revolutionized the management of advanced GIST. However, following initiation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkataraman, Vinayak, George, Suzanne, Cote, Gregory M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Sarcomas
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400151/
https://www.ncbi.nlm.nih.gov/pubmed/37315115
http://dx.doi.org/10.1093/oncolo/oyad167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400151/
https://www.ncbi.nlm.nih.gov/pubmed/37315115
http://dx.doi.org/10.1093/oncolo/oyad167

Ejemplares similares